These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9801720)

  • 1. Personality disorders in drug abusers: prevalence and their association with AXIS I disorders as predictors of treatment retention.
    Kokkevi A; Stefanis N; Anastasopoulou E; Kostogianni C
    Addict Behav; 1998; 23(6):841-53. PubMed ID: 9801720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating substance abuse is not enough: comorbidities in consecutively admitted female prisoners.
    Mir J; Kastner S; Priebe S; Konrad N; Ströhle A; Mundt AP
    Addict Behav; 2015 Jul; 46():25-30. PubMed ID: 25770695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mood, anxiety and personality disorders in patients with systemic lupus erythematosus.
    Uguz F; Kucuk A; Cicek E; Kayhan F; Tunc R
    Compr Psychiatry; 2013 May; 54(4):341-5. PubMed ID: 23246099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual diagnosis and chronology of illness in treatment-seeking Italian patients dependent on heroin.
    Maremmani AG; Dell'Osso L; Pacini M; Popovic D; Rovai L; Torrens M; Perugi G; Maremmani I
    J Addict Dis; 2011 Apr; 30(2):123-35. PubMed ID: 21491294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axis I and II psychiatric disorders in patients with traumatic brain injury: a 12-month follow-up study.
    Koponen S; Taiminen T; Hiekkanen H; Tenovuo O
    Brain Inj; 2011; 25(11):1029-34. PubMed ID: 21870901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personality disorders: epidemiology and public health issues.
    Samuels J
    Int Rev Psychiatry; 2011 Jun; 23(3):223-33. PubMed ID: 21923224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric comorbidity and the persistence of drug use disorders in the United States.
    Fenton MC; Keyes K; Geier T; Greenstein E; Skodol A; Krueger B; Grant BF; Hasin DS
    Addiction; 2012 Mar; 107(3):599-609. PubMed ID: 21883607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance use and mental diagnoses among adults with and without type 2 diabetes: Results from electronic health records data.
    Wu LT; Ghitza UE; Batch BC; Pencina MJ; Rojas LF; Goldstein BA; Schibler T; Dunham AA; Rusincovitch S; Brady KT
    Drug Alcohol Depend; 2015 Nov; 156():162-169. PubMed ID: 26392231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personality disorders and retention in a therapeutic community for substance dependence.
    Samuel DB; LaPaglia DM; Maccarelli LM; Moore BA; Ball SA
    Am J Addict; 2011; 20(6):555-62. PubMed ID: 21999502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large variation of severity and longitudinal change of symptom distress among patients with personality disorders.
    Kvarstein EH; Karterud S
    Personal Ment Health; 2013 Nov; 7(4):265-76. PubMed ID: 24343976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatric comorbidity in refractory focal epilepsy: a study of 490 patients.
    Dalmagro CL; Velasco TR; Bianchin MM; Martins AP; Guarnieri R; Cescato MP; Carlotti CG; Assirati JA; Araújo D; Santos AC; Hallak JE; Sakamoto AC
    Epilepsy Behav; 2012 Dec; 25(4):593-7. PubMed ID: 23159384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and determinants of personality disorders in a clinical sample of alcohol-, drug-, and dual-dependent patients.
    Colpaert K; Vanderplasschen W; De Maeyer J; Broekaert E; De Fruyt F
    Subst Use Misuse; 2012 May; 47(6):649-61. PubMed ID: 22288949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly-substance use and antisocial personality traits at admission predict cumulative retention in a buprenorphine programme with mandatory work and high compliance profile.
    Öhlin L; Hesse M; Fridell M; Tätting P
    BMC Psychiatry; 2011 May; 11():81. PubMed ID: 21569440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiety disorders among offenders with antisocial personality disorders: a distinct subtype?
    Hodgins S; De Brito SA; Chhabra P; Côté G
    Can J Psychiatry; 2010 Dec; 55(12):784-91. PubMed ID: 21172099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of prevalence of Personality Disorders in inmate men sample with Substance Use Disorders using of PDQ-4+ Self-Report.
    Calvo N; Nasillo V; Ferrer M; Valero S; Perez-Conill Rde S; Rovira-Machordom M; Molina-Fernandez M; Casas M
    Actas Esp Psiquiatr; 2016 Sep; 44(5):178-82. PubMed ID: 27644099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and characteristics of cluster B personality disorder in a consultation-liaison psychiatry practice.
    Mergui J; Raveh D; Gropp C; Golmard JL; Jaworowski S
    Int J Psychiatry Clin Pract; 2015 Mar; 19(1):65-70. PubMed ID: 25363196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of comorbid alcohol use disorder in the presence of personality disorder: Systematic review and explanatory modelling.
    Guy N; Newton-Howes G; Ford H; Williman J; Foulds J
    Personal Ment Health; 2018 Aug; 12(3):216-228. PubMed ID: 29611335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Did you get any help? A post-hoc secondary analysis of a randomized controlled trial of psychoeducation for patients with antisocial personality disorder in outpatient substance abuse treatment programs.
    Thylstrup B; Schrøder S; Fridell M; Hesse M
    BMC Psychiatry; 2017 Jan; 17(1):7. PubMed ID: 28068951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A Systematic Review of Personality Disorders and Addiction: Epidemiology, Course and Treatment].
    Euler S; Sollberger D; Bader K; Lang UE; Walter M
    Fortschr Neurol Psychiatr; 2015 Oct; 83(10):544-54. PubMed ID: 26588717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interactive effects of antisocial personality disorder and court-mandated status on substance abuse treatment dropout.
    Daughters SB; Stipelman BA; Sargeant MN; Schuster R; Bornovalova MA; Lejuez CW
    J Subst Abuse Treat; 2008 Mar; 34(2):157-64. PubMed ID: 17869050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.